非体外循环与体外循环冠状动脉旁路移植术后再次血运重建的荟萃分析
该荟萃分析纳入11项前瞻性随机对照试验共11,246例患者,比较非体外循环与体外循环冠状动脉旁路移植术后的再次血运重建率。固定效应模型显示,非体外循环组1年随访再次血运重建率显著增加(OR 1.53,95%CI 1.17-2.00,p=0.002),5年随访两组无显著差异(OR 1.16,95%CI 0.95-1.41,p=0.14)。
要点
- 非体外循环组1年再次血运重建率较体外循环组显著增加(OR 1.53,95%CI 1.17-2.00,p=0.002)。
- 5年随访两组再次血运重建率无显著差异(OR 1.16,95%CI 0.95-1.41,p=0.14)。
- 排除任何单项试验不影响1年和5年结果,无显著发表偏倚证据。
核心结论
- 荟萃分析结果提示,与体外循环冠状动脉旁路移植术相比,非体外循环冠状动脉旁路移植术增加1年随访再次血运重建率,但不影响5年随访的再次血运重建率。
研究设计与样本
- 荟萃分析检索PubMed、EMBASE、Cochrane Library和ISI Web of Knowledge数据库1966年至2017年10月的文献。
- 纳入标准为比较非体外循环与体外循环冠状动脉旁路移植术的前瞻性随机临床试验,结局包括1个月、1年或5年随访时的再次血运重建率。
- 共纳入11项随机对照试验,总计11,246例患者随机分配至非体外循环或体外循环冠状动脉旁路移植术。
主要发现
- 固定效应模型显示,非体外循环组1年随访再次血运重建率较体外循环组显著增加53%(OR 1.53,95%CI 1.17-2.00,p=0.002)。
- 固定效应模型显示,5年随访非体外循环组与体外循环组再次血运重建率无显著差异(OR 1.16,95%CI 0.95-1.41,p=0.14)。
- 排除任何单项试验均不影响1年和5年随访的再次血运重建率结果。
- 无显著发表偏倚证据。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is an ongoing debate focusing on clinical outcomes after off-pump coronary artery bypass graft surgery (OPCABG) and on-pump coronary artery bypass graft surgery (ONCABG). The objective of the present meta-analysis is to update and compare repeat revascularization rates between OPCABG and ONCABG procedures. METHODS: Data sources including PubMed, EMBASE, Cochrane Library, and ISI Web of Knowledge were searched between 1966 and October 2017. Studies considered for inclusion should conform to the following criteria: prospective randomized clinical trials comparing OPCABG and ONCABG. Outcome should include repeat revascularization rate at the time of 1-month, 1-year, or 5-year follow-up. RESULTS: A literature search yielded 11 randomized controlled trials, and a total of 11,246 patients were randomly allocated to OPCABG or ONCABG procedures. Pooled analysis demonstrated a statistically significant 53% increase in repeat revascularization rate at 1-year follow-up with OPCABG relative to ONCABG in the fixed effects model (odds ratio 1.53, 95% confidence interval: 1.17 to 2.00, p = 0.002), whereas there was no significant difference in repeat revascularization rate at 5-year follow-up between OPCABG and ONCABG in the fixed effects model (OR 1.16, 95% confidence interval: 0.95 to 1.41, p = 0.14). In general, exclusion of any single trial did not affect repeat revascularization rate at 1-year and 5-year follow-up. There was no evidence of significant publication bias. CONCLUSIONS: The result of our meta-analysis suggests that compared with ONCABG, OPCABG increases repeat revascularization rate at 1-year follow-up, but does not affect that of 5-year follow-up.
引用
- Zhou P, Zhu P, Xiao Z, et al. Meta-Analysis of Repeat Revascularization of Off-Pump and On-Pump Coronary Artery Bypass Surgery. Ann Thorac Surg. 2018. PMID: 29608874. doi:10.1016/j.athoracsur.2018.02.068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。